Laboratorium für Klinische Forschung GmbH (LKF) becomes GBA Central Lab Services GmbH

New Name, Unified Brand Identity, Proven Quality

The Laboratorium für Klinische Forschung GmbH (LKF), a member of the GBA Group, will now operate under the new company brand GBA Central Lab Services GmbH (GBA CLS). The rebranding initiative represents a strategic direction aimed at aligning the company’s identity with the global GBA Group and at communicating the core service with the company name. It reflects a clear commitment to enhancing international visibility, creating a consistent brand presence across all markets, and positioning GBA Central Lab Services GmbH as a unified and globally recognized provider of central laboratory services.

As a member of the GBA Group’s global network, GBA CLS offers a significantly broader portfolio of services to support clinical trials across all phases. This includes expert consulting, project management, logistics and provisioning of laboratory kits, laboratory analyses, data management and reporting, as well as specimen storage—all from one single, trusted source.

Following the transition to the new company name, the updated contact information is provided below:

GBA Central Lab Services GmbH
Lise-Meitner-Str. 25–29
24223 Schwentinental
Germany
Phone: +49 4307 8276-0
Email: project-cls@gba-group.com
Website: GBA CLS

“With the transition to GBA CLS, we are positioning ourselves even more clearly as a global partner for central laboratory services in clinical trials. Our promise remains unchanged: quality, expertise, and customer focus at the highest level - now under one unified international brand,” say the Managing Directors of GBA CLS Dr. Volker El-Samalouti and Dr. Gerrit Schönicke.